Detalhe da pesquisa
1.
CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy.
Oncoimmunology
; 13(1): 2338965, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38590799